Antimetabolite Immunosuppressant class drugs

4 results
Accord Healthcare Inc.
Usage: Mycophenolic acid delayed release tablets are indicated for preventing organ rejection in adult and pediatric kidney transplant patients, used alongside cyclosporine and corticosteroids. They should not be interchanged with mycophenolate mofetil without medical supervision due to differing absorption rates.
CONCORD BIOTECH LIMITED
Usage: Mycophenolic acid delayed-release tablets are indicated for preventing organ rejection in kidney transplant patients aged 5 and older, used alongside cyclosporine and corticosteroids. It is not interchangeable with mycophenolate mofetil without physician supervision due to differing absorption rates.
A-S Medication Solutions
Usage: Mycophenolic acid delayed-release tablets are indicated for preventing organ rejection in adult and pediatric kidney transplant patients, used in combination with cyclosporine and corticosteroids. Interchangeability with mycophenolate mofetil (MMF) products requires physician supervision due to differing absorption rates.
Ascend Laboratories, LLC
Usage: Mycophenolic acid delayed-release tablets are indicated for preventing organ rejection in kidney transplant patients, both adults and pediatric patients aged 5 and older, in combination with cyclosporine and corticosteroids. Interchangeability with mycophenolate mofetil is not recommended without physician supervision due to absorption differences.